| 2024-06-24 |
Discovery of dual MER/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment |
Journal of Medicinal Chemistry. 2024 Jun 24;Article in Press. |
 |
| 2005-05 |
Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers |
Journal of Human Genetics. 2005 May;50(5):249-258. |
|
| 2020-08-20 |
Discovery of M protease inhibitors encoded by SARS-CoV-2 |
Antimicrobial Agents and Chemotherapy. 2020 Aug 20;64(9):e00872-20. |
|
| 2014-11 |
Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent |
European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93. |
|
| 2010-12 |
Discovery of non-glycoside sodium-dependent glucose Co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening |
Journal of Medicinal Chemistry. 2010 Dec;53(24):8770-8774. |
|
| 2023-10 |
Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs |
Annals of Oncology. 2023 Oct;34(Suppl. 2):S214. |
|
| 2016-11-29 |
Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design |
European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199. |
|
| 2011-01-13 |
Discovery of novel N -Beta- d -Xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes |
Journal of Medicinal Chemistry. 2011 Jan 13;54(1):166-178. |
|
| 2012-02 |
Discovery of novel stem cell mobilizers that target the CXCR4 receptor |
ChemMedChem. 2012 Feb;7(2):209-212. |
|
| 2022-03-02 |
Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy |
Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782. |
|
| 2014-08 |
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells |
Oncotarget. 2014 Aug;5(15):6087-6101. |
|
| 2020-04 |
Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis |
FASEB Journal. 2020 Apr;34(S1):Abstract number 08868. |
|
| 2023-10-05 |
Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease |
European Journal of Medicinal Chemistry. 2023 Oct 05;258:Article number 115583. |
|
| 2014-09 |
Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists |
Bioorganic and Medicinal Chemistry. 2014 Sep;22(17): 4694-4703. |
|
| 2017-01 |
Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists |
European Journal of Medicinal Chemistry. 2017 Jan;126:202-217. |
|
| 2023-01-11 |
Discrepant activation pattern of inflammation and pyroptosis induced in dermal fibroblasts in response to dengue virus serotypes 1 and 2 and nonstructural protein 1 |
Microbiology Spectrum. 2023 Jan;11(1):Article number e0358622. |
|
| 2016-04-21 |
The discrete random-effects model-assessing benefit and consistency of treatment effect |
Multiregional Clinical Trials for Simultaneous Global New Drug Development. 2016 Apr 21:245-258. |
|
| 2021-05 |
Discriminating subcortical ischemic vascular disease and Alzheimer's disease by diffusion kurtosis imaging in segregated thalamic regions |
Human Brain Mapping. 2021 May;42(7):2018-2031. |
|
| 2022-05-16 |
Discrimination of methicillin-resistant staphylococcus aureus by MALDI-TOF mass spectrometry with machine learning techniques in patients with staphylococcus aureus bacteremia |
Pathogens. 2022 May 16;11(5):Article number 586. |
|
| 2014-11 |
Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration |
Clinical and Experimental Rheumatology. 2014 Nov-Dec ;32(6):898-903. |
|
| 2015-01 |
Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration.[Erratum: Clinical and Experimental Rheumatology. 2014 Nov-Dec ;32(6):898-903.] |
Clinical and Experimental Rheumatology. 2015 Jan;33(1):135. |
|
| 2022-11 |
Disease burden and demographic characteristics of mucormycosis: A nationwide population-based study in Taiwan, 2006-2017 |
Mycoses. 2022 Nov;65(11):1001-1009. |
|
| 2009-02 |
Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005 |
Journal of Microbiology, Immunology and Infection. 2009 Feb;42(1):5-12. |
|
| 2010-02 |
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan |
Vaccine. 2010 Feb;28(5):1217-1220 |
|
| 2006-12-15 |
Disease burden and related medical costs of rotavirus infections in Taiwan |
BMC Infectious Diseases. 2006 Dec;6:Article number 176. |
|
